Summary
The COVID-19 pandemic has exposed a global need for accelerating research, improving surveillance, and efficiently developing countermeasures against pathogens with epidemic and pandemic potential. LEAPS aims to demonstrate the value and feasibility of a pro-active policy-supporting strategy for genomic surveillance and for pandemic preparedness and response, by delivering a system-wide stakeholder-validated proof of concept, validated in 4 EU countries, of a learning and adaptive European pandemic preparedness system against pathogen X.
LEAPS will fill the gaps observed by global, EU (HERA) and national stakeholders in pandemic response by demonstrating the feasibility of combining genomic One Health surveillance, with genomic epidemiologic modeling for detailed pathogen understanding and precise public health intervention design. LEAPS formalizes dynamic health emergency threat assessment linked to the initiation of governance mechanisms to enable timely decisions in crucial, early stages of an outbreak. LEAPS will develop protocols and models for accelerated medical countermeasure development, availability and accessibility. Based on resulting highly effective intervention strategies, timely countermeasure access and governance mechanisms, model-based policy support is proposed to health authorities for effective, implementable, stakeholder co-created epidemic response scenarios against pathogen X. Scenarios are evaluated on health, socio-economic, and sustainability impact.
LEAPS brings together a unique multidisciplinary team with optimal complementary expertise and experience. LEAPS will interact regularly with medical and scientific communities, HERA and health authorities in order to disseminate relevant and accessible information, and during non-emergency periods LEAPS will validate a roadmap for large-scale implementation of LEAPS methodology by EU level, and national authorities and stakeholders in an ecosystem of interlinked actors.
LEAPS will fill the gaps observed by global, EU (HERA) and national stakeholders in pandemic response by demonstrating the feasibility of combining genomic One Health surveillance, with genomic epidemiologic modeling for detailed pathogen understanding and precise public health intervention design. LEAPS formalizes dynamic health emergency threat assessment linked to the initiation of governance mechanisms to enable timely decisions in crucial, early stages of an outbreak. LEAPS will develop protocols and models for accelerated medical countermeasure development, availability and accessibility. Based on resulting highly effective intervention strategies, timely countermeasure access and governance mechanisms, model-based policy support is proposed to health authorities for effective, implementable, stakeholder co-created epidemic response scenarios against pathogen X. Scenarios are evaluated on health, socio-economic, and sustainability impact.
LEAPS brings together a unique multidisciplinary team with optimal complementary expertise and experience. LEAPS will interact regularly with medical and scientific communities, HERA and health authorities in order to disseminate relevant and accessible information, and during non-emergency periods LEAPS will validate a roadmap for large-scale implementation of LEAPS methodology by EU level, and national authorities and stakeholders in an ecosystem of interlinked actors.
Unfold all
/
Fold all
More information & hyperlinks
| Web resources: | https://cordis.europa.eu/project/id/101094685 |
| Start date: | 01-10-2023 |
| End date: | 30-09-2027 |
| Total budget - Public funding: | 2 999 600,00 Euro - 2 999 600,00 Euro |
Cordis data
Original description
The COVID-19 pandemic has exposed a global need for accelerating research, improving surveillance, and efficiently developing countermeasures against pathogens with epidemic and pandemic potential. LEAPS aims to demonstrate the value and feasibility of a pro-active policy-supporting strategy for genomic surveillance and for pandemic preparedness and response, by delivering a system-wide stakeholder-validated proof of concept, validated in 4 EU countries, of a learning and adaptive European pandemic preparedness system against pathogen X.LEAPS will fill the gaps observed by global, EU (HERA) and national stakeholders in pandemic response by demonstrating the feasibility of combining genomic One Health surveillance, with genomic epidemiologic modeling for detailed pathogen understanding and precise public health intervention design. LEAPS formalizes dynamic health emergency threat assessment linked to the initiation of governance mechanisms to enable timely decisions in crucial, early stages of an outbreak. LEAPS will develop protocols and models for accelerated medical countermeasure development, availability and accessibility. Based on resulting highly effective intervention strategies, timely countermeasure access and governance mechanisms, model-based policy support is proposed to health authorities for effective, implementable, stakeholder co-created epidemic response scenarios against pathogen X. Scenarios are evaluated on health, socio-economic, and sustainability impact.
LEAPS brings together a unique multidisciplinary team with optimal complementary expertise and experience. LEAPS will interact regularly with medical and scientific communities, HERA and health authorities in order to disseminate relevant and accessible information, and during non-emergency periods LEAPS will validate a roadmap for large-scale implementation of LEAPS methodology by EU level, and national authorities and stakeholders in an ecosystem of interlinked actors.
Status
SIGNEDCall topic
HORIZON-HLTH-2022-DISEASE-07-02Update Date
12-03-2024
Images
No images available.
Geographical location(s)
Structured mapping
Unfold all
/
Fold all
